| Financial Year |
March 31 2023 |
| Monetary Funds |
1,144,875,565.43 |
| Held-for-trading Financial Assets |
26,241,545.07 |
| Notes Receivable |
13,130,264.42 |
| Accounts Receivable |
706,344,626.40 |
| Advances to Suppliers |
109,300,471.87 |
| Other Receivables |
119,937,942.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
562,697,996.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,250,032.38 |
| Total Current Assets |
2,734,778,443.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
379,964,007.66 |
| Investment Properties |
17,754,651.25 |
| Fixed Assetes |
907,814,908.95 |
| Under-construction Projects |
538,702,076.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
285,223,139.31 |
| R&D expenses |
3,114,090.47 |
| Goodwill |
537,217,225.05 |
| Long-Term Deferred and Prepaid Expenses |
34,034,994.96 |
| Deferred Income Tax Assets |
62,584,045.87 |
| Other Non-Current Assets |
248,034,580.95 |
| Sub-Total of Non-Current Assets |
3,181,840,040.96 |
| Total Assets |
5,916,618,484.71 |
| Short-Term Loans |
115,649,645.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
323,604,451.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,693,326.52 |
| Taxes Payable |
8,863,881.66 |
| Interest Payable |
-- |
| Dividend Payable |
19,475,000.00 |
| Other payables |
78,699,888.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,627,367.09 |
| Other Current Liabilities |
195.63 |
| Sub-Total of Current Liabilities |
586,937,899.09 |
| Long-term Loans |
418,550,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
435,794.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
903,475.64 |
| Deferred Income Tax Liabilities |
39,428,364.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
703,180,249.43 |
| Total Liabilities |
1,290,118,148.52 |
| Paid-In Capital(Or Share Stock) |
947,922,645.00 |
| Capital Surplus |
1,890,984,652.71 |
| Surplus Reserve |
194,805,506.77 |
| LESS:Treasury Stock |
200,010,636.96 |
| Undistributed Profits |
1,451,099,726.53 |
| Minority Stockholder's Interest |
340,460,407.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,286,039,928.28 |
| Owner's Equity（Stockholder's Equity） |
4,626,500,336.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,916,618,484.71 |
